ASEP Medical Holdings Inc.
ASEP Medical Holdings Inc.
Asep Medical Holdings Inc. (asepmedical.com) is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine. The Company is a consolidation of three existing private companies all with technology in advanced development — Sepset Biosciences Inc. (proprietary diagnostic tools to enable the early and timely identification of sepsis), ABT Innovations Inc. (broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections), and SafeCoat Medical Inc. (an antibacterial peptide medical device coating technology).
ASEP Medical Holdings Inc. (ASEP)
SEDAR Information
Company Info
Capitalization
Company Officers
News Releases
Bulletins
2025-0421 - Consolidation - ASEP Medical Holdings Inc. (ASEP)
Le 15 avril/April 2025
ASEP Medical Holdings Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.
As a result, the number of outstanding shares will be reduced to approximately 11,127,327 common shares.
The name and symbol will not change.
